UNSPSC 41202040: Mycoplasma spp. serological reagents

In this classification, Mycoplasma genus serological reagents are devices used in test to identify specific Mycoplasma genus antibodies in serum. US FDA regulates Mycoplasma genus serological reagents under 21 CFR 866.3375 and under FDA product code GSB.

UNSPSC 41202040 Mycoplasma spp. serological reagents is a Commodity code that in practice captures state and local procurement of HIV and Syphilis testing reagents, diagnostic assays, and related laboratory supplies used in public health and criminal justice specimen screening. The recent state and local opportunities under this code show a pronounced mismatch between the code's nominal scope (Mycoplasma serology) and actual purchasing activity, which centers on HIV, Syphilis, and Hepatitis B and C testing kits, reagents, calibrators, controls, and automated or nonautomated assay systems. Issuing bodies include state health departments, county criminal supervision agencies, municipal public health programs, and university health centers. The Illinois Department of Public Health appears as a repeat buyer, posting emergency and open procurements for Abbott-manufactured HIV and Syphilis reagents and screening instrumentation across multiple fiscal years. Texas state and local agencies—the Texas Department of Criminal Justice and Collin County Community Supervision and Corrections Department—also solicit under this code for offender drug and pathogen testing services that include HIV screening as a subordinate component. Public health and criminal justice mission drives the purchasing; cost and lab certification dominate evaluation.

Geographic activity concentrates in Illinois, Texas, and Florida, with secondary activity in other states. The Illinois Department of Public Health has posted four recent solicitations (February through May 2026) for HIV and Syphilis reagents and related screening assays, including an emergency sole-source award to Abbott Laboratories and a competitive five-year IFB for fully automated combination screening instrumentation with renewal options. Collin County, Texas issued RFP 2026-327 (due July 23, 2026) for offender specimen collection and drug testing services including HIV/Hepatitis screening at two sites, estimated at $600,000 annually, with a two-year initial term and up to three one-year renewals. The City of Austin issued IFB 9100AAM1023 (due July 17, 2026) for rapid HIV test kits (Abbott Determine line) to support the Austin Public Health Program. The Texas Department of Criminal Justice posted an RFP for forensic analysis services including serology and DNA testing capability (due May 13, 2026). The University of Houston released RFP-730-UofH-3109 for clinical diagnostic laboratory services including blood chemistry and nonautomated diagnostic testing (due March 24, 2026). Activity is heaviest in the second and third quarters of 2026, with annual contract values ranging from tens of thousands to $600,000, procurement vehicles split between RFP, RFQ, IFB, and ITB, and SAMHSA, CAP, and ISO/IEC 17025 lab certification or FDA clearance commonly required.